News for 'Pharma industry'

Electoral bonds: Who is lottery king Santiago Martin?

Electoral bonds: Who is lottery king Santiago Martin?

Rediff.com15 Mar 2024

Future Gaming and Hotel Services whose director is the lottery magnate Santiago Martin is the top purchaser of electoral bonds having purchased bonds worth Rs 1,368, according to data uploaded by the Election Commission of India on its website on Thursday.

India will not provide data exclusivity: Sharma

India will not provide data exclusivity: Sharma

Rediff.com30 Mar 2011

Data exclusivity provides protection to the technical data generated by innovator companies to prove the merit of usefulness of their products.

IT, pharma firms have lion's share biz travel spend

IT, pharma firms have lion's share biz travel spend

Rediff.com19 Jan 2017

Apart from IT and pharma, the lead spenders in travel are construction, automobile and metals and mining companies and together these sectors accounted for 82 per cent of business travel spend in India in 2015, up from 78 per cent in 2013.

Sensex jumped 333 points to close at 66,599

Sensex jumped 333 points to close at 66,599

Rediff.com8 Sep 2023

From the Sensex pack, NTPC, Tata Motors, Larsen & Toubro, Bajaj Finserv, Bharti Airtel, HDFC Bank, Reliance Industries, Titan, Power Grid and State Bank of India were the major gainers. ITC, UltraTech Cement, Tech Mahindra, Tata Steel, Wipro, Tata Consultancy Services and JSW Steel were among the laggards.

Sun Pharma seeks shareholders' nod for Rs 12,000-crore QIP

Sun Pharma seeks shareholders' nod for Rs 12,000-crore QIP

Rediff.com12 Sep 2014

Sun Pharma stated the company wanted shareholders' approval to "issue, offer and allot equity shares or non-convertible securities, other than warrants, up to an amount of Rs 12,000 crore ($2 billion), to qualified institutional buyers pursuant to a QIP."

Integration challenges: Sun Pharma's next hurdle

Integration challenges: Sun Pharma's next hurdle

Rediff.com23 Apr 2015

The challenge of merging Ranbaxy into the company has not been factored in.

Samvat 2080 starts on a high; Sensex ends up 355 points

Samvat 2080 starts on a high; Sensex ends up 355 points

Rediff.com12 Nov 2023

Among the Sensex shares, Infosys rose the most by 1.37 per cent, followed by Larsen & Toubro (0.90 per cent), and Wipro (0.83 per cent). HDFC Bank, ICICI Bank, Reliance Industries, ITC, TCS, Kotak Bank, Asian Paints and Titan were among the lead gainers.

Electoral bonds: Congress flags mismatch in donor, recipient files

Electoral bonds: Congress flags mismatch in donor, recipient files

Rediff.com15 Mar 2024

It also asked why the data shared pertained to a period from April 2019 even though the scheme for anonymous political funding was introduced in 2017.

Post COVID-19: 'IT industry will emerge stronger'

Post COVID-19: 'IT industry will emerge stronger'

Rediff.com10 Apr 2020

'We have to plan for whatever the new normal is.'

Govt to implement barcoding of medicines

Govt to implement barcoding of medicines

Rediff.com15 Mar 2011

The Ministry of Commerce and Industry will go ahead with the proposal for 2D barcoding and a unique 'randomly generated numeric code' on packets of medicine destined for export, a senior official said.

Sensex surges 629 points; RIL jumps 2.79%

Sensex surges 629 points; RIL jumps 2.79%

Rediff.com26 May 2023

Sun Pharma, Hindustan Unilever, HCL Technologies, Wipro, Tech Mahindra, UltraTech Cement, Tata Steel and Titan were among the other major gainers. Bharti Airtel, Power Grid and NTPC were the laggards.

Court orders temporary halt on Sun Pharma's takeover of Ranbaxy

Court orders temporary halt on Sun Pharma's takeover of Ranbaxy

Rediff.com1 May 2014

Two individuals filed the petition in the high court of Andhra Pradesh

Sensex tumbles 796 points; Nifty closes below 20K

Sensex tumbles 796 points; Nifty closes below 20K

Rediff.com20 Sep 2023

Among the Sensex firms, HDFC Bank emerged as the biggest loser, falling 4 per cent. JSW Steel, Reliance Industries, UltraTech Cement, Maruti, Tata Steel, Wipro, Tech Mahindra, Bharti Airtel and Larsen & Toubro were the other major laggards. Power Grid, Asian Paints, Sun Pharma, Axis Bank, NTPC, ITC and Infosys were among the gainers.

Post takeover, Sun Pharma to rebrand Ranbaxy drugs in the US

Post takeover, Sun Pharma to rebrand Ranbaxy drugs in the US

Rediff.com9 Apr 2014

Ranbaxy drugs sold in the United States will be gradually rebranded as Sun Pharma treatments

Drug price control to get stricter

Drug price control to get stricter

Rediff.com16 Aug 2006

8 core industries' output contracts to record 6.5% in March

8 core industries' output contracts to record 6.5% in March

Rediff.com30 Apr 2020

The record contraction in the growth rate of eight core sectors will have its impact on IIP.

Indian drugmakers facing takeover threat: Panel

Indian drugmakers facing takeover threat: Panel

Rediff.com4 May 2009

According to industry experts, there are more than 10,000 drug manufacturers in the country and most of them are small-sector units operating in the generic segment. With a large number of drugs going off-patent in developed markets like the US and Europe, Indian companies are expected to garner a lion's share in the segment.

11 food, pharma organisations seek CBI inquiry against FSSAI

11 food, pharma organisations seek CBI inquiry against FSSAI

Rediff.com1 Oct 2015

As many as 11 industry bodies related to food and pharma sectors on Thursday alleged that the food regulator FSSAI has become "den of corruption" and demanded a CBI inquiry into the functioning of the authority, which shot to limelight over the Maggi issue.

Pharma, engineering power exports to 6.16% y-on-y growth in Jan

Pharma, engineering power exports to 6.16% y-on-y growth in Jan

Rediff.com15 Feb 2021

Trade deficit during the month narrowed to USD 14.54 billion from USD 15.3 billion in January 2020. It was USD 15.44 billion in December 2020.

Why Dolo, Saridon, Calpol Will Have QR Codes

Why Dolo, Saridon, Calpol Will Have QR Codes

Rediff.com8 Aug 2023

The top 300 pharmaceutical brands in the country will now bear a quick response (QR) code on their packaging to rein in spurious drugs and ensure better traceability.

Pharma firms look to profit from waste

Pharma firms look to profit from waste

Rediff.com15 May 2009

For instance, Dr Reddy's Laboratories has six active pharmaceutical units in Andhra Pradesh. The waste streams from the API units mostly contain potassium sulphate, caustic lye, potassium chloride, potassium sulphate and sodium sulphate salts.

New policy may cost pharma firms Rs 3,000 crore: Industry

New policy may cost pharma firms Rs 3,000 crore: Industry

Rediff.com5 Dec 2011

The pharmaceutical companies may suffer sales loss of Rs 3,000 crore (Rs 30 billion) if the government's span of control increases, as proposed in the new pricing policy for the medicines, a section of the industry said on Monday.

SPECIAL: Why SC got it right on Novartis

SPECIAL: Why SC got it right on Novartis

Rediff.com7 Apr 2013

The judgment will save taxpayers' money without hurting the pharma industry or R&D.

EC reveals electoral bond donors, but not who gave which party

EC reveals electoral bond donors, but not who gave which party

Rediff.com15 Mar 2024

From steel tycoon Lakshmi Mittal to billionaire Sunil Bharti Mittal's Airtel, Anil Agarwal's Vedanta, ITC, Mahindra and Mahindra, and a lesser-known Future Gaming and Hotel Services were among the prominent buyers of the now-scrapped electoral bonds for making political donations.

Sensex ends in red; Nifty edges up 26 points

Sensex ends in red; Nifty edges up 26 points

Rediff.com26 Jun 2023

From the Sensex pack, Tata Consultancy Services, Reliance Industries, NTPC, Bharti Airtel, Power Grid, Larsen & Toubro, HDFC Bank, Kotak Mahindra Bank, Tech Mahindra and HDFC were the major laggards. Maruti, Tata Motors, Titan, UltraTech Cement, Bajaj Finserv, Mahindra & Mahindra, State Bank of India and IndusInd Bank were the biggest gainers.

Nifty could see another 8-10% upside in 2024: HDFC Securities

Nifty could see another 8-10% upside in 2024: HDFC Securities

Rediff.com27 Dec 2023

The benchmark Nifty and Sensex could see another 8-10 per cent from the current levels, said HDFC Securities in its outlook for equity markets in 2024. The brokerage said that the market movement in the next year will not be linear, and there will be more volatility. When asked about the market reaction to the General Elections in 2024, Dhiraj Relli, managing director and CEO of HDFC Securities, said more than the outcome of the elections, the market movement in the next three to four months will decide the market trajectory post elections.

 Sun Pharma slumps after $550 mn patent suit settlement with Pfizer

Sun Pharma slumps after $550 mn patent suit settlement with Pfizer

Rediff.com13 Jun 2013

Shares in Sun Pharmaceutical Industries fell by more than 5 per cent after the company settled a patent suit with Pfizer Inc related to its acid-reflux drug for $550 million.

Market litmus may turn red for chemicals sector

Market litmus may turn red for chemicals sector

Rediff.com22 Jan 2024

The chemicals sector's recovery could be delayed until FY25 if the current trends of weak demand and flat pricing continue. Following a subdued September quarter, the revenue and profit performance of listed chemicals companies are anticipated to fall short of initial expectations of an improvement. Despite some price stability, the demand trajectory remains uncertain.

Pharma shares boost markets; Dr Reddy's Labs, Lupin lead

Pharma shares boost markets; Dr Reddy's Labs, Lupin lead

Rediff.com6 Aug 2015

Asian markets were trading mixed with the Nikkei gaining after the US dollar strengthened against the yen.

Fake 'Made-in-India' drugs exported from China

Fake 'Made-in-India' drugs exported from China

Rediff.com11 Jun 2009

'Taking serious note of the action by unscrupulous elements to malign the Indian generic pharma industry, the embassy of India, Beijing, has been requested to lodge a strong protest with concerned Chinese authorities and also to impress upon them to take stringent action against such unscrupulous elements,' a commerce ministry statement said in New Delhi.

India, EFTA sign $100-billion free trade pact

India, EFTA sign $100-billion free trade pact

Rediff.com10 Mar 2024

Domestic customers will get access to high-quality Swiss products such as watches, chocolates, biscuits, and clocks at lower prices as India will phase out customs duties under its trade pact with the EFTA bloc on these goods over a period of time. India and the four-European nation bloc EFTA signed a trade and economic partnership agreement (TEPA) on Sunday to boost trade and investments between the two regions. The European Free Trade Association (EFTA) members are Iceland, Liechtenstein, Norway, and Switzerland.

Equity markets settle higher for 2nd day

Equity markets settle higher for 2nd day

Rediff.com7 Aug 2023

Sun Pharma, Bajaj Finserv, Tata Consultancy Services, Infosys, Hindustan Unilever, JSW Steel, Wipro, Maruti, HCL Technologies, Tech Mahindra and ICICI Bank were the other major gainers. State Bank of India, Tata Motors, Axis Bank, Kotak Mahindra Bank, Bajaj Finance, Tata Steel, Nestle and HDFC Bank were the laggards.

We should respect sovereignty: PM's message to China, Pak at SCO summit

We should respect sovereignty: PM's message to China, Pak at SCO summit

Rediff.com10 Nov 2020

In his address, the PM also hit out at those making repeated attempts to "unnecessarily" bring bilateral issues to the SCO in violation of the grouping's foundational principles, in an oblique reference to Pakistan.

'Respect sovereignty': PM's message to China, Pak at SCO summit

'Respect sovereignty': PM's message to China, Pak at SCO summit

Rediff.com10 Nov 2020

The remarks by Modi at a virtual SCO summit came in the backdrop of the Sino-India border row.

Hiring to remain robust in pharma in 2011

Hiring to remain robust in pharma in 2011

Rediff.com27 Dec 2010

According to a Pricewaterhouse Coopers Report titled 'India Pharma Inc: Capitalising on India's Growth Potential', leading pharmaceutical companies in the country have increased their sales forces by around 50 per cent in 2010.

Equity capital market league tables see a significant reshuffle at the top

Equity capital market league tables see a significant reshuffle at the top

Rediff.com13 Oct 2023

Jefferies, IIFL, and JM Financial - none of which were in the top five last year - have now claimed the top spots in the league tables for equity capital markets (ECM) during the first nine months of calendar year 2023 (CY23), a period characterised by small- and mid-sized transactions. This shift marks a significant change, with these firms outperforming the bulge-bracket investment banks. According to data provided by Refinitiv, Jefferies leads the domestic ECM market, having handled share sales worth $2.3 billion, representing 12.4 per cent of the total volume of $18.4 billion for ECM transactions.

Sun Pharma profit down 30% over compliance costs, lower sales

Sun Pharma profit down 30% over compliance costs, lower sales

Rediff.com7 Nov 2015

Sun Pharma profit down 30% over compliance costs, lower sales.